{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:42:45Z","timestamp":1786372965039,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2]]},"abstract":"Summary<\/jats:title>\n \n Background and objectives<\/jats:title>\n \n Chronic pain and psychiatric disorders are common in dialysis patients, but the extent to which opioids and benzodiazepines are used is unclear. We conducted a systematic review to determine the: (\n 1<\/jats:italic>\n ) prevalence of opioid and benzodiazepine use among dialysis patients; (\n 2<\/jats:italic>\n ) reasons for use; (\n 3<\/jats:italic>\n ) effectiveness of symptom control; and (\n 4<\/jats:italic>\n ) incidence of adverse events.\n <\/jats:p>\n <\/jats:sec>\n \n Design, setting, participants, & measurements<\/jats:title>\n Two authors reviewed all relevant citations in MEDLINE\/EMBASE\/CINAHL\/BIOSIS Previews\/Cochrane and hand-searched bibliographies. Studies after 1990 reporting prevalence estimates for opioid and\/or benzodiazepine use in \u226550 dialysis patients were included.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n We identified 15 studies from 12 countries over 1995 to 2006. Sample size ranged from 75 to 12,782. Prevalence of opioid and benzodiazepine use was variable, ranging from 5 to 36% (95% CI, 4.1 to 45.5%;\n n<\/jats:italic>\n = 10) and 8 to 26% (95% CI, 7.1 to 27.3%;\n n<\/jats:italic>\n = 9), respectively. Prevalence was positively correlated with years on dialysis. Five studies reported on the same cohorts but gave different prevalence estimates. One study verified medication use through patient interviews. Reasons for use were reported in one study. Effectiveness of pain control varied from 17 to 38%, and 72 to 84% of patients with significant pain had no analgesia (\n n<\/jats:italic>\n = 2). No study rigorously examined for adverse events.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The prevalence of opioid and benzodiazepine use in dialysis patients is highly variable between centers. Further information is needed regarding the appropriateness of these prescriptions, adequacy of symptom control, and incidence of adverse effects in this population.<\/jats:p>\n <\/jats:sec>","DOI":"10.2215\/cjn.04770610","type":"journal-article","created":{"date-parts":[[2010,11,11]],"date-time":"2010-11-11T20:56:28Z","timestamp":1289508988000},"page":"326-333","source":"Crossref","is-referenced-by-count":65,"title":["Opioid and Benzodiazepine Use in End-Stage Renal Disease"],"prefix":"10.2215","volume":"6","author":[{"given":"Ahraaz","family":"Wyne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meaghan","family":"Cuerden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita S.","family":"Suri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-14-20230811","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0272-6386(97)90342-5","article-title":"Quality of life in patients on chronic dialysis: Self-assessment 3 months after the start of treatment: The Necosad Study Group","volume":"29","author":"Merkus","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"R3-14-20230811","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/ajkd.2001.26824","article-title":"Quality of life in end-stage renal disease patients","volume":"38","author":"Valderrabano","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"R4-14-20230811","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1053\/ajkd.2002.36879","article-title":"Health-related quality of life, depressive symptoms, anemia, and malnutrition at hemodialysis initiation","volume":"40","author":"Walters","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R5-14-20230811","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/heart.87.3.235","article-title":"Health related quality of life in patients with congestive heart failure: Comparison with other chronic diseases and relation to functional variables","volume":"87","author":"Juenger","year":"2002","journal-title":"Heart"},{"key":"R6-14-20230811","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.ackd.2006.10.001","article-title":"The prevalence of symptoms in end-stage renal disease: A systematic review","volume":"14","author":"Murtagh","year":"2007","journal-title":"Adv Chronic Kidney Dis"},{"key":"R7-14-20230811","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1053\/j.ajkd.2003.08.025","article-title":"Pain in hemodialysis patients: Prevalence, etiology, severity, and analgesic use","volume":"42","author":"Davison","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R8-14-20230811","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0272-6386(03)00645-0","article-title":"Analgesia in patients with ESRD: A review of available evidence","volume":"42","author":"Kurella","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R9-14-20230811","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0272-6386(05)80018-6","article-title":"Identification and treatment of depression in a cohort of patients maintained on chronic peritoneal dialysis","volume":"37","author":"Wuerth","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"R11-14-20230811","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E","article-title":"Two-sided confidence intervals for the single proportion: Comparison of seven methods","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"key":"R12-14-20230811","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R13-14-20230811","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1111\/j.1523-1755.2004.00658.x","article-title":"Analgesic prescription patterns among hemodialysis patients in the DOPPS: Potential for underprescription","volume":"65","author":"Bailie","year":"2004","journal-title":"Kidney Int"},{"key":"R14-14-20230811","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1038\/sj.ki.5001832","article-title":"Symptoms of depression, prescription of benzodiazepines, and the risk of death in hemodialysis patients in Japan","volume":"70","author":"Fukuhara","year":"2006","journal-title":"Kidney Int"},{"key":"R15-14-20230811","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1053\/j.ajkd.2005.07.001","article-title":"Medication related problems in ambulatory hemodialysis patients: A pooled analysis","volume":"46","author":"Manley","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R16-14-20230811","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/sj.ki.5002548","article-title":"Benzodiazepine use and mortality of incident dialysis patients in the United States","volume":"72","author":"Winkelmayer","year":"2007","journal-title":"Kidney Int"},{"key":"R17-14-20230811","doi-asserted-by":"crossref","first-page":"802","DOI":"10.2215\/CJN.00710206","article-title":"Sleep quality and its correlates in the first year of dialysis","volume":"1","author":"Unruh","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R18-14-20230811","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/ajhp\/57.9.902","article-title":"Comparing medication use in two hemodialysis units against national dialysis databases","volume":"57","author":"Manley","year":"2000","journal-title":"Am J Health Syst Pharm"},{"key":"R19-14-20230811","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/j.ajkd.2004.09.027","article-title":"Falls in hemodialysis patients: Prospective study of incidence, risk factors and complications","volume":"45","author":"Desmet","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R20-14-20230811","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/ndt\/gfm630","article-title":"Sleep quality predicts quality of life and mortality risk in haemodialysis patients: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"23","author":"Elder","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R21-14-20230811","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1542-4758.2006.00092.x","article-title":"Large variations in prescriptions of gastrointestinal medications in hemodialysis patients on three continents: The Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"10","author":"Bailie","year":"2006","journal-title":"Hemodial Int"},{"key":"R22-14-20230811","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/ndt\/gfl755","article-title":"Sexual dysfunction in dialysis patients treated with antihypertensive or antidepressive medications: Results from the DOPPS","volume":"22","author":"Bailie","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R23-14-20230811","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","article-title":"Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study","volume":"70","author":"Jadoul","year":"2006","journal-title":"Kidney Int"},{"key":"R24-14-20230811","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0272-6386(96)90256-5","article-title":"Postdialysis fatigue","volume":"28","author":"Sklar","year":"1996","journal-title":"Am J Kindey Dis"},{"key":"R25-14-20230811","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1542-4758.2008.00264.x","article-title":"Clinical correlates and treatment of bone\/joint pain and difficult with sexual arousal in patients on maintenance hemodialysis","volume":"12","author":"Carreon","year":"2008","journal-title":"Hemodial Int"},{"key":"R26-14-20230811","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5055\/jom.2008.0019","article-title":"Epidemiology of opioid pharmacy claims in the United States","volume":"4","author":"Williams","year":"2008","journal-title":"J Opioid Manag"},{"key":"R27-14-20230811","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0885-3924(01)00396-7","article-title":"Chronic pain prevalence and analgesic prescribing in a general medical population","volume":"23","author":"Clark","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"R28-14-20230811","first-page":"142","article-title":"Physical function, employment and quality of life in end-stage renal disease","volume":"13","author":"Blake","year":"2000","journal-title":"J Nephrol"},{"key":"R29-14-20230811","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1681\/ASN.2005020157","article-title":"Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients","volume":"16","author":"Weisbord","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R30-14-20230811","first-page":"773","article-title":"Effects of renal insufficiency on the pharmacokinetics and pharmacodynamics of opioid analgesics","volume":"21","author":"Chan","year":"1987","journal-title":"Drug Intell Clin Pharm"},{"key":"R31-14-20230811","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2174\/138945010791170879","article-title":"The use of major analgesics in patients with renal dysfunction","volume":"11","author":"Niscola","year":"2010","journal-title":"Curr Drug Targets"},{"key":"R33-14-20230811","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0885-3924(95)00187-5","article-title":"Opioid therapy for chronic nonmalignant pain: A review of the critical issues","volume":"11","author":"Portenoy","year":"1996","journal-title":"J Pain Symptom Manage"},{"key":"R34-14-20230811","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1681\/ASN.2006050477","article-title":"Efficacy of the world health organization analgesic ladder to treat pain in end-stage renal disease","volume":"17","author":"Barakzoy","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R35-14-20230811","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpain.2004.11.009","article-title":"Treatment of pain in patients with renal insufficiency: The World Health Organization three-step ladder adapted","volume":"6","author":"Launay-Vacher","year":"2005","journal-title":"J Pain"},{"key":"R36-14-20230811","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0272-6386(96)90046-3","article-title":"Analgesics and the kidney: Summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation","volume":"27","author":"Henrich","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"R37-14-20230811","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.cct.2010.06.005","article-title":"Methodology of a randomized clinical trial of symptom management strategies in patients receiving chronic hemodialysis: The SMILE Study","volume":"31","author":"Weisbord","year":"2010","journal-title":"Contemp Clin Trials"},{"key":"R38-14-20230811","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1478-7954-4-15","article-title":"Hypnotic use in a population-based sample of over thirty-five thousand interviewed Canadians","volume":"4","author":"Kassam","year":"2006","journal-title":"Popul Health Metr"},{"key":"R39-14-20230811","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00228-004-0808-2","article-title":"Patterns and correlates of benzodiazepine use in the French general population","volume":"60","author":"Lagnaoui","year":"2004","journal-title":"Eur J Clin Pharmacol"},{"key":"R40-14-20230811","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002280050063","article-title":"Use of benzodiazepines in the Italian general population: Prevalence, pattern of use and risk factors for use","volume":"50","author":"Magrini","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"key":"R41-14-20230811","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1592\/phco.23.2.231.32079","article-title":"Drug record discrepancies in an outpatient electronic medical record: Frequency, type, and potential impact on patient care at a hemodialysis center","volume":"23","author":"Manley","year":"2003","journal-title":"Pharmacotherapy"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201102000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:40:29Z","timestamp":1786369229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201102000-00014"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.04770610","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}